Journal of Shandong University (Health Sciences) ›› 2024, Vol. 62 ›› Issue (11): 67-72.doi: 10.6040/j.issn.1671-7554.0.2024.0504
• Clinical Medicine • Previous Articles
WU Siyu1,2, SHEN Yelong2, WANG Ximing1,2
CLC Number:
[1] Farrall AL, Smith JR. Changing incidence and survival of primary central nervous system lymphoma in Australia: a 33-year national population-based study[J]. Cancers, 2021, 13(3): 403. doi:10.3390/cancers13030403. [2] Bi SC, Li J, Wang TY, et al. Multi-parametric MRI-based radiomics signature for preoperative prediction of Ki-67 proliferation status in sinonasal malignancies: a two-centre study[J]. Eur Radiol, 2022, 32(10): 6933-6942. [3] Küker W, Nägele T, Korfel A, et al. Primary central nervous system lymphomas(PCNSL): MRI features at presentation in 100 patients[J]. J Neurooncol, 2005, 72(2): 169-177. [4] Wieduwilt MJ, Valles F, Issa S, et al. Immunochemotherapy with intensive consolidation for primary CNS lymphoma: a pilot study and prognostic assessment by diffusion-weighted MRI[J]. Clin Cancer Res, 2012, 18(4): 1146-1155. [5] Chen T, Liu YB, Wang Y, et al. Evidence-based expert consensus on the management of primary central nervous system lymphoma in China[J]. J Hematol Oncol, 2022, 15(1): 136. doi:10.1186/s13045-022-01356-7. [6] Lohmann P, Franceschi E, Vollmuth P, et al. Radiomics in neuro-oncological clinical trials[J]. Lancet Digit Health, 2022, 4(11): 841-849. [7] Dohan A, Gallix B, Guiu B, et al. Early evaluation using a radiomic signature of unresectable hepatic metastases to predict outcome in patients with colorectal cancer treated with FOLFIRI and bevacizumab[J]. Gut, 2020, 69(3): 531-539. [8] 董春桐, 毛宁, 谢海柱, 等. 影像组学及深度学习在预测乳腺癌新辅助化疗疗效中的研究进展[J]. 医学影像学杂志, 2023, 33(4): 652-656. DONG Chuntong, MAO Ning, XIE Haizhu, et al. Research progress of radiomics and deep learning in predicting the response to neoadjuvant chemotherapy for breast cancer[J]. Journal of Medical Imaging, 2023, 33(4): 652-656. [9] Cho U, Oh WJ, Hong YK, et al. Prognostic significance of high ki-67 index and histogenetic subclassification in primary central nervous system lymphoma[J]. Appl Immunohistochem Mol Morphol, 2018, 26(4): 254-262. [10] Schaff LR, Grommes C. Primary central nervous system lymphoma[J]. Blood, 2022, 140(9): 971-979. [11] Kaulen LD, Baehring JM. Treatment options for recurrent primary CNS lymphoma[J]. Curr Treat Options Oncol, 2022, 23(11): 1548-1565. [12] Neelakantan S, Kumaran SP, Viswamitra S, et al. Myriad of MR imaging phenotypes of primary central nervous system lymphoma in a cohort of immunocompetent Indian patient population[J]. Indian J Radiol Imaging, 2018, 28(3): 296-304. [13] Holdhoff M, Mrugala MM, Grommes C, et al. Challenges in the treatment of newly diagnosed and recurrent primary central nervous system lymphoma[J]. J Natl Compr Canc Netw, 2020, 18(11): 1571-1578. [14] Yang H, Xun Y, Yang AP, et al. Advances and challenges in the treatment of primary central nervous system lymphoma[J]. J Cell Physiol, 2020, 235(12): 9143-9165. [15] Luchini C, Pantanowitz L, Adsay V, et al. Ki-67 assessment of pancreatic neuroendocrine neoplasms: systematic review and meta-analysis of manual vs. digital pathology scoring[J]. Mod Pathol, 2022, 35(6): 712-720. [16] Raverot G, Ilie MD, Lasolle H, et al. Aggressive pituitary tumours and pituitary carcinomas[J]. Nat Rev Endocrinol, 2021, 17(11): 671-684. [17] Lenschow C, Schrägle S, Kircher S, et al. Clinical presentation, treatment, and outcome of parathyroid carcinoma: results of the NEKAR retrospective international multicenter study[J]. Ann Surg, 2022, 275(2): e479-e487. [18] 边毓尧, 石向明. 常规 MR联合 DWI成像鉴别小脑原发性中枢神经系统淋巴瘤与高级别胶质瘤的价值[J]. 中国实验诊断学, 2024, 28(2): 127-131. BIAN Yuyao, SHI Xiangming. The value of conventional MR combined with DWI imaging in differential diagnosis ofp rimary cerebellar central nervous system lymphoma and advanced glioma [J]. Chinese Journal of Laboratory Diagnosis, 2024, 28(2): 127-131. [19] Chen H, Li W, Wan C, et al. Correlation of dynamic contrast-enhanced MRI and diffusion-weighted MR imaging with prognostic factors and subtypes of breast cancers[J]. Front Oncol, 2022, 12: 942943. doi:10.3389/fonc.2022.942943. [20] Hu XX, Yang ZX, Liang HY, et al. Whole-tumor MRI histogram analyses of hepatocellular carcinoma: correlations with Ki-67 labeling index[J]. J Magn Reson Imaging, 2017, 46(2): 383-392. [21] Schob S, Meyer J, Gawlitza M, et al. Diffusion-weighted MRI reflects proliferative activity in primary CNS lymphoma[J]. PLoS One, 2016, 11(8): e0161386. doi:10.1371/journal.pone.0161386. [22] Zhang B, Tian J, Dong D, et al. Radiomics features of multiparametric MRI as novel prognostic factors in advanced nasopharyngeal carcinoma[J]. Clin Cancer Res, 2017, 23(15): 4259-4269. [23] Chen MY, Cao JS, Hu JH, et al. Clinical-radiomic analysis for pretreatment prediction of objective response to first transarterial chemoembolization in hepatocellular carcinoma[J]. Liver Cancer, 2021, 10(1): 38-51. [24] Bera K, Braman N, Gupta A, et al. Predicting cancer outcomes with radiomics and artificial intelligence in radiology[J]. Nat Rev Clin Oncol, 2022, 19(2): 132-146. [25] Sun R, Limkin EJ, Vakalopoulou M, et al. A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study[J]. Lancet Oncol, 2018, 19(9): 1180-1191. [26] Xue KM, Liu L, Liu YX, et al. Radiomics model based on multi-sequence MR images for predicting preoperative immunoscore in rectal cancer[J]. Radiol Med, 2022, 127(7): 702-713. [27] Huang EP, OConnor JPB, McShane LM, et al. Criteria for the translation of radiomics into clinically useful tests[J]. Nat Rev Clin Oncol, 2023, 20(2): 69-82. [28] Xia W, Hu B, Li HQ, et al. Multiparametric-MRI-based radiomics model for differentiating primary central nervous system lymphoma from glioblastoma: development and cross-vendor validation[J]. J Magn Reson Imaging, 2021, 53(1): 242-250. [29] Bathla G, Priya S, Liu YN, et al. Radiomics-based differentiation between glioblastoma and primary central nervous system lymphoma: a comparison of diagnostic performance across different MRI sequences and machine learning techniques[J]. Eur Radiol, 2021, 31(11): 8703-8713. [30] Kang D, Park JE, Kim YH, et al. Diffusion radiomics as a diagnostic model for atypical manifestation of primary central nervous system lymphoma: development and multicenter external validation[J]. Neuro Oncol, 2018, 20(9): 1251-1261. |
[1] | LIU Xiaowen, CAO Yongquan, HOU Mingyuan, YU Dexin. Value of multiple quantitative parameters of EOB-MRI in the risk assessment of progression of HHN in hepatobiliary phase [J]. Journal of Shandong University (Health Sciences), 2024, 62(4): 31-39. |
[2] | JIN Xinjuan, ZUO Liping, DENG Zhanhao, LI Anning, YU Dexin. Value of enhanced MRI radiomics in predicting the drug-resistant protein PFKFB3 in 135 cases of hepatocellular carcinoma [J]. Journal of Shandong University (Health Sciences), 2023, 61(6): 79-86. |
[3] | LI Qing, ZHANG Anna, DU Yansheng, DIAO Jiuzhou, CUI Ruojin, FU Pengrui, YUE Xinyi, ZHOU Qingbo. Influencing factors of the transformation of single demyelinating lesion of spinal cord in 47 cases [J]. Journal of Shandong University (Health Sciences), 2023, 61(5): 37-43. |
[4] | LIU Yan, LENG Shanshan, XIA Xiaona, DONG Hao, HUANG Chencui, MENG Xiangshui. Functional outcomes of 376 patients with supratentorial spontaneous intracerebral hemorrhage based on radiomic parameters [J]. Journal of Shandong University (Health Sciences), 2023, 61(5): 59-67. |
[5] | WANG Lei, ZHANG Shuai, LIU Gang, YOU Shengnan, WANG Zhi, ZHU Shan, CHEN Chao, MA Xinlong, YANG Qiang. Comparison of MRI diagnosis of 140 cases of MCs using intelligent network automatic detection and classification methods [J]. Journal of Shandong University (Health Sciences), 2023, 61(3): 71-79. |
[6] | YANG Yongqing, ZHAO Peng, WANG Yu, MA Wenjing, TIAN Mimi, CHENG Yani, ZU Lu, LIN Xiangtao. Diagnostic value of extracellular volume fraction in 62 cases of different pathological types of lung cancer [J]. Journal of Shandong University (Health Sciences), 2023, 61(2): 88-94. |
[7] | ZHU Zhengyang, SHEN Jingfei, CHEN Sixuan, YE Meiping, YANG Huiquan, ZHOU Jianan, LIANG Xue, ZHANG Xin, ZHANG Bing. Prediction of isocitrate dehydrogenase mutation in glioma with different radiomic models based on susceptibility-weighted imaging [J]. Journal of Shandong University (Health Sciences), 2023, 61(12): 44-50. |
[8] | JIN Xinjuan, CAI Daxing, FAN Jinlei, DENG Zhanhao, LI Nan, YU Dexin, LI Anning. Differentiation of benign and malignant skin focal protuberant nodules using microscope high-resolution MRI [J]. Journal of Shandong University (Health Sciences), 2023, 61(12): 51-61. |
[9] | JIAO Guangli, SHI Zixin, CHEN Rong, SONG Yabo, YANG Fei, CUI Shujun. Radiomics of enhanced CT in predicting the response to platinum-based chemotherapy for ovarian cancer [J]. Journal of Shandong University (Health Sciences), 2023, 61(12): 62-69. |
[10] | AI Jiangshan, GAO Huijiang, AI Shiwen, LI Hengyan, SHI Guodong, WEI Yucheng. Diagnostic value of CT radiomics in lung cancer associated with cystic airspaces [J]. Journal of Shandong University (Health Sciences), 2023, 61(12): 70-77. |
[11] | ZHAO Enju, ZHAO Shuo, GUO Yunliang, WANG Ximing. Association between carotid calcification and MRI overall burden in 282 cases of cerebral small vessel disease [J]. Journal of Shandong University (Health Sciences), 2023, 61(1): 38-44. |
[12] | TAO Guowei, WANG Fang, DONG Xiangyi, XU Yaxuan, ZHAO Linli, HU Beibei. Diagnosis of adenomyosis using ultrasound and magnetic resonance imaging [J]. Journal of Shandong University (Health Sciences), 2022, 60(7): 56-65. |
[13] | SUN Haoyu, JIANG Xin, CHEN Shouzhen, QU Sifeng, SHI Benkang. Multiparametric magnetic resonance imaging combined with prostate health index in the diagnosis of prostate cancer in 142 patients within PSA grey zone [J]. Journal of Shandong University (Health Sciences), 2022, 60(6): 46-50. |
[14] | GAO Lin, YU Xinxin, KANG Bing, ZHANG Shuai, WANG Ximing. Predictive value of CT-based radiomics nomogram for the invasiveness of lung pure ground-glass nodules [J]. Journal of Shandong University (Health Sciences), 2022, 60(5): 87-97. |
[15] | YUAN Hongtao, JI Congshan, KANG Bing, QIN Songnan, YU Xinxin, GAO Lin, WANG Ximing. Diagnostic value of CT radiomics nomogram for adrenal lipid-poor adenoma and nodular hyperplasia [J]. Journal of Shandong University (Health Sciences), 2022, 60(4): 68-75. |
|